http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100417669-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0827 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-087 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08 |
| filingDate | 1999-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100417669-B1 |
| titleOfInvention | Ethylamine derivatives |
| abstract | An object of the present invention is to provide an ethylamine derivative which exhibits a motilin receptor antagonist action and the like and is useful as a medicine.n n n According to the present invention, Chemical Formula 1:n n n [Formula 1]n n n n n n n n (Wherein R 1 is a phenyl group, R 2 is a hydrogen atom, R 3 is a hydrogen atom, R 4 is a hydrogen atom, R 5 is an alkyl group, R 7 is a hydrogen atom, R 8 is a heterocyclic ring, etc.) There is provided a compound, a hydrate thereof, or a pharmaceutically acceptable salt thereof and a medicament containing such a compound as an active ingredient. |
| priorityDate | 1998-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 186.